News

The agency could continue to pursue more extensive LDT oversight by tightening control over items like RUO reagents and specimen collection devices.
The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.
VIENNA – Irish researchers presented data Saturday at the European Society of Clinical Microbiology and Infectious Diseases global congress validating interleukin-6 as an early detection biomarker for ...
NEW YORK – NanoSpeed Diagnostics announced on Tuesday that it has obtained regulatory approval in Canada for a qualitative test to assess vitamin D in a fingertip blood sample at the point of care.
VIENNA – Irish researchers presented data Saturday at the European Society of Clinical Microbiology and Infectious Diseases global congress validating interleukin-6 as an early detection biomarker for ...
NEW YORK – Cancer Research Horizons, a translational subsidiary of Cancer Research UK, announced Monday that it has awarded £230,000 ($302,582) to researchers at the University of Birmingham to ...
The firm raised the money last week in a public offering of 14,375,000 common shares, and it will use the money for working capital and general corporate purposes.
The all-stock deal combines Longevity's human longevity and health aging products with 20/20s lab tests including its OneTest multi-cancer early detection assay.
Last week, readers were most interested in a story about Roche ramping up the commercialization of its sample self-collection devices for HPV.
The Amsterdam-based firm's PCR-based Molecular Culture ID test is used to detect more than 200 bacterial species, yielding results within five hours.
Jasmine Hoyle was accused of using Medicaid beneficiaries' information to file false claims for drug tests that were never performed.